Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approach

Chem Commun (Camb). 2025 Nov 13;61(92):18108-18111. doi: 10.1039/d5cc03325j.

Abstract

The direct-to-biology (D2B) approach enables biological screening of crude reaction mixtures, eliminating the need for purification steps and thereby accelerating drug discovery. In this study, we developed a miniaturized D2B platform for the rapid synthesis of proteolysis targeting chimera (PROTAC) degraders of soluble epoxide hydrolase (sEH). We used copper-catalyzed azide-alkyne cycloaddition and optimized the conditions for 384-well PCR plate applications with 10 μL reaction volumes on a 300 nmol scale. This approach enabled the D2B synthesis of 92 crude PROTACs from azide-functionalized CRBN-ligands and alkyne-linked sEH inhibitors. Biological screening using a HiBiT lytic degradation assay identified two hits that were resynthesized and exhibited subnanomolar DC50 values and degradation efficacy (Dmax). Thus, we established a scalable, cost-effective and time-saving D2B platform for the discovery of PROTACs in very small quantities. This methodology is particularly suitable for early-stage screening and hit validation assessing the degradability of a target.

MeSH terms

  • Alkynes / chemistry
  • Azides / chemistry
  • Click Chemistry
  • Copper / chemistry
  • Cycloaddition Reaction
  • Enzyme Inhibitors* / chemical synthesis
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / pharmacology
  • Epoxide Hydrolases* / antagonists & inhibitors
  • Epoxide Hydrolases* / metabolism
  • Humans
  • Molecular Structure
  • Proteolysis / drug effects
  • Proteolysis Targeting Chimera

Substances

  • Epoxide Hydrolases
  • Alkynes
  • Enzyme Inhibitors
  • Azides
  • Copper
  • Proteolysis Targeting Chimera